Literature DB >> 28192016

New Insulins, Biosimilars, and Insulin Therapy.

Thomas Danne1, Lutz Heinemann2, Jan Bolinder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28192016     DOI: 10.1089/dia.2017.2505

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


× No keyword cloud information.
  1 in total

1.  An Empirical Analysis of the Perceived Challenges and Benefits of Introducing Biosimilars in Bangladesh: A Paradigm Shift.

Authors:  Eva Rahman Kabir; Shannon Sherwin Moreino; Mohammad Kawsar Sharif Siam
Journal:  Biomolecules       Date:  2018-09-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.